Citius Oncology, Inc. CTOR Class of Warrant or Right, Outstanding
Class of Warrant or Right, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s class of warrant or right, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s class of warrant or right, outstanding?
- Citius Oncology, Inc. (CTOR) reported class of warrant or right, outstanding of $38.65M in Q1 2026.